ID   IRAK4_HUMAN             Reviewed;         460 AA.
AC   Q9NWZ3; Q8TDF7; Q9Y589;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   02-NOV-2010, entry version 96.
DE   RecName: Full=Interleukin-1 receptor-associated kinase 4;
DE            Short=IRAK-4;
DE            EC=2.7.11.1;
DE   AltName: Full=Renal carcinoma antigen NY-REN-64;
GN   Name=IRAK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INTERACTION WITH IRAK1 AND
RP   TRAF6.
RX   MEDLINE=21957277; PubMed=11960013; DOI=10.1073/pnas.082100399;
RA   Li S., Strelow A., Fontana E.J., Wesche H.;
RT   "IRAK4: a novel member of the IRAK family with the properties of an
RT   IRAK-kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:5567-5572(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND IDENTIFICATION AS A RENAL CANCER
RP   ANTIGEN.
RX   MEDLINE=99438124; PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-98; ARG-390 AND
RP   THR-428.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INVOLVEMENT IN IRAK4 DEFICIENCY.
RX   PubMed=12925671; DOI=10.1084/jem.20030701;
RA   Medvedev A.E., Lentschat A., Kuhns D.B., Blanco J.C.G., Salkowski C.,
RA   Zhang S., Arditi M., Gallin J.I., Vogel S.N.;
RT   "Distinct mutations in IRAK-4 confer hyporesponsiveness to
RT   lipopolysaccharide and interleukin-1 in a patient with recurrent
RT   bacterial infections.";
RL   J. Exp. Med. 198:521-531(2003).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS OF LYS-213.
RX   PubMed=15084582; DOI=10.1074/jbc.M400785200;
RA   Qin J., Jiang Z., Qian Y., Casanova J.-L., Li X.;
RT   "IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-
RT   associated kinase phosphorylation and IL-1 responsiveness.";
RL   J. Biol. Chem. 279:26748-26753(2004).
RN   [8]
RP   INVOLVEMENT IN IRAK4 DEFICIENCY.
RX   PubMed=12637671; DOI=10.1126/science.1081902;
RA   Picard C., Puel A., Bonnet M., Ku C.-L., Bustamante J., Yang K.,
RA   Soudais C., Dupuis S., Feinberg J., Fieschi C., Elbim C.,
RA   Hitchcock R., Lammas D., Davies G., Al-Ghonaium A., Al-Rayes H.,
RA   Al-Jumaah S., Al-Hajjar S., Al-Mohsen I.Z., Frayha H.H., Rucker R.,
RA   Hawn T.R., Aderem A., Tufenkeji H., Haraguchi S., Day N.K., Good R.A.,
RA   Gougerot-Pocidalo M.-A., Ozinsky A., Casanova J.-L.;
RT   "Pyogenic bacterial infections in humans with IRAK-4 deficiency.";
RL   Science 299:2076-2079(2003).
RN   [9]
RP   INTERACTION WITH IL1RL1.
RX   PubMed=16286016; DOI=10.1016/j.immuni.2005.09.015;
RA   Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K.,
RA   Zurawski G., Moshrefi M., Qin J., Li X., Gorman D.M., Bazan J.F.,
RA   Kastelein R.A.;
RT   "IL-33, an interleukin-1-like cytokine that signals via the IL-1
RT   receptor-related protein ST 2 and induces T helper type 2-associated
RT   cytokines.";
RL   Immunity 23:479-490(2005).
RN   [10]
RP   INVOLVEMENT IN IPD1.
RX   PubMed=16950813; DOI=10.1136/jmg.2006.044446;
RA   Ku C.-L., Picard C., Erdos M., Jeurissen A., Bustamante J., Puel A.,
RA   von Bernuth H., Filipe-Santos O., Chang H.-H., Lawrence T., Raes M.,
RA   Marodi L., Bossuyt X., Casanova J.-L.;
RT   "IRAK4 and NEMO mutations in otherwise healthy children with recurrent
RT   invasive pneumococcal disease.";
RL   J. Med. Genet. 44:16-23(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-3 AND LYS-34, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-5; VAL-355; HIS-391 AND THR-428.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Required for the efficient recruitment of IRAK1 to the
CC       IL-1 receptor complex following IL-1 engagement, triggering
CC       intracellular signaling cascades leading to transcriptional up-
CC       regulation and mRNA stabilization. Phosphorylates IRAK1.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- SUBUNIT: IL-1 stimulation leads to the formation of a signaling
CC       complex which dissociates from the IL-1 receptor following the
CC       binding of PELI1. Interacts with IL1RL1.
CC   -!- INTERACTION:
CC       Q01638:IL1RL1; NbExp=1; IntAct=EBI-448378, EBI-993762;
CC       Q9HAT8:PELI2; NbExp=2; IntAct=EBI-448378, EBI-448407;
CC   -!- DISEASE: Defects in IRAK4 are the cause of recurrent isolated
CC       invasive pneumococcal disease type 1 (IPD1) [MIM:610799].
CC       Recurrent invasive pneumococcal disease (IPD) is defined as two
CC       episodes of IPD occurring at least 1 month apart, whether caused
CC       by the same or different serotypes or strains. Recurrent IPD
CC       occurs in at least 2% of patients in most series, making IPD the
CC       most important known risk factor for subsequent IPD.
CC   -!- DISEASE: Defects in IRAK4 are the cause of IRAK4 deficiency
CC       [MIM:607676]. IRAK4 deficiency causes extracellular pyogenic
CC       bacterial and fungal infections in otherwise healthy children.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. Pelle subfamily.
CC   -!- SIMILARITY: Contains 1 death domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=IRAK4base; Note=IRAK4 mutation db;
CC       URL="http://bioinf.uta.fi/IRAK4base/";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/irak4/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF445802; AAM15772.1; -; mRNA.
DR   EMBL; AF155118; AAD42884.1; -; mRNA.
DR   EMBL; AK000528; BAA91232.1; -; mRNA.
DR   EMBL; AY186092; AAN75440.1; -; Genomic_DNA.
DR   EMBL; BC013316; AAH13316.1; -; mRNA.
DR   IPI; IPI00007641; -.
DR   RefSeq; NP_001107654.1; -.
DR   RefSeq; NP_057207.2; -.
DR   UniGene; Hs.138499; -.
DR   PDB; 2NRU; X-ray; 2.00 A; A/B/C/D=154-460.
DR   PDB; 2NRY; X-ray; 2.15 A; A/B/C/D=154-460.
DR   PDB; 2O8Y; X-ray; 2.40 A; A/B=163-460.
DR   PDB; 2OIB; X-ray; 2.00 A; A/B/C/D=160-460.
DR   PDB; 2OIC; X-ray; 2.40 A; A/B/C/D=160-460.
DR   PDB; 2OID; X-ray; 2.30 A; A/B/C/D=160-460.
DR   PDB; 3MOP; X-ray; 3.40 A; G/H/I/J=4-106.
DR   PDBsum; 2NRU; -.
DR   PDBsum; 2NRY; -.
DR   PDBsum; 2O8Y; -.
DR   PDBsum; 2OIB; -.
DR   PDBsum; 2OIC; -.
DR   PDBsum; 2OID; -.
DR   PDBsum; 3MOP; -.
DR   ProteinModelPortal; Q9NWZ3; -.
DR   SMR; Q9NWZ3; 1-113.
DR   DIP; DIP-31351N; -.
DR   IntAct; Q9NWZ3; 9.
DR   MINT; MINT-1383671; -.
DR   STRING; Q9NWZ3; -.
DR   PRIDE; Q9NWZ3; -.
DR   Ensembl; ENST00000356669; ENSP00000349096; ENSG00000198001.
DR   Ensembl; ENST00000448290; ENSP00000390651; ENSG00000198001.
DR   GeneID; 51135; -.
DR   KEGG; hsa:51135; -.
DR   UCSC; uc001rnt.2; human.
DR   CTD; 51135; -.
DR   GeneCards; GC12P044152; -.
DR   H-InvDB; HIX0021737; -.
DR   HGNC; HGNC:17967; IRAK4.
DR   HPA; CAB016685; -.
DR   HPA; CAB022077; -.
DR   HPA; HPA000924; -.
DR   MIM; 606883; gene.
DR   MIM; 607676; phenotype.
DR   MIM; 610799; phenotype.
DR   Orphanet; 70592; Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency.
DR   PharmGKB; PA134914577; -.
DR   HOGENOM; HBG713523; -.
DR   HOVERGEN; HBG066836; -.
DR   InParanoid; Q9NWZ3; -.
DR   OMA; MRCKIAQ; -.
DR   OrthoDB; EOG9DZ4FM; -.
DR   PhylomeDB; Q9NWZ3; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; il1pathway; IL1-mediated signaling events.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 53983; -.
DR   ArrayExpress; Q9NWZ3; -.
DR   Bgee; Q9NWZ3; -.
DR   CleanEx; HS_IRAK4; -.
DR   Genevestigator; Q9NWZ3; -.
DR   GermOnline; ENSG00000198001; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0007249; P:I-kappaB kinase/NF-kappaB cascade; EXP:Reactome.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR011029; DEATH-like.
DR   InterPro; IPR017428; Interleukin-1_rcpt-assoc_kin4.
DR   InterPro; IPR015787; Interleukin1_rcpt-assoc_kin4_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   Gene3D; G3DSA:1.10.533.10; DEATH_like; 1.
DR   PANTHER; PTHR23258:SF428; IRAK4; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF038189; IRAK4; 1.
DR   SUPFAM; SSF47986; DEATH_like; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50017; DEATH_DOMAIN; FALSE_NEG.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Kinase;
KW   Magnesium; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    460       Interleukin-1 receptor-associated kinase
FT                                4.
FT                                /FTId=PRO_0000086035.
FT   DOMAIN       20    104       Death.
FT   DOMAIN      186    454       Protein kinase.
FT   NP_BIND     192    200       ATP (By similarity).
FT   ACT_SITE    311    311       Proton acceptor (By similarity).
FT   BINDING     213    213       ATP.
FT   MOD_RES       3      3       N6-acetyllysine.
FT   MOD_RES      34     34       N6-acetyllysine.
FT   MOD_RES     152    152       Phosphoserine.
FT   VARIANT       5      5       I -> V (in dbSNP:rs56312115).
FT                                /FTId=VAR_040588.
FT   VARIANT      98     98       S -> R (in dbSNP:rs4251469).
FT                                /FTId=VAR_019354.
FT   VARIANT     355    355       M -> V.
FT                                /FTId=VAR_040589.
FT   VARIANT     390    390       H -> R (in dbSNP:rs4251583).
FT                                /FTId=VAR_019355.
FT   VARIANT     391    391       R -> H (in dbSNP:rs55944915).
FT                                /FTId=VAR_040590.
FT   VARIANT     428    428       A -> T (in dbSNP:rs4251545).
FT                                /FTId=VAR_019356.
FT   MUTAGEN     213    213       K->A: Loss of kinase activity.
FT   CONFLICT     81     81       V -> A (in Ref. 1; AAM15772).
FT   CONFLICT    432    432       V -> G (in Ref. 2; AAD42884).
FT   CONFLICT    437    437       L -> R (in Ref. 2; AAD42884).
FT   CONFLICT    444    444       R -> S (in Ref. 2; AAD42884).
FT   CONFLICT    451    451       Q -> H (in Ref. 2; AAD42884).
FT   HELIX       170    176
FT   TURN        177    180
FT   HELIX       185    187
FT   STRAND      190    193
FT   STRAND      200    205
FT   STRAND      208    214
FT   HELIX       227    236
FT   HELIX       237    239
FT   STRAND      248    252
FT   STRAND      254    257
FT   STRAND      259    263
FT   HELIX       270    274
FT   HELIX       277    279
FT   HELIX       285    304
FT   HELIX       314    316
FT   STRAND      317    319
FT   STRAND      325    327
FT   HELIX       352    354
FT   HELIX       357    360
FT   HELIX       366    382
FT   STRAND      389    395
FT   HELIX       396    398
FT   HELIX       399    404
FT   HELIX       410    413
FT   HELIX       423    436
FT   HELIX       441    443
FT   HELIX       447    458
SQ   SEQUENCE   460 AA;  51530 MW;  6C8156ADF25FF81E CRC64;
     MNKPITPSTY VRCLNVGLIR KLSDFIDPQE GWKKLAVAIK KPSGDDRYNQ FHIRRFEALL
     QTGKSPTSEL LFDWGTTNCT VGDLVDLLIQ NEFFAPASLL LPDAVPKTAN TLPSKEAITV
     QQKQMPFCDK DRTLMTPVQN LEQSYMPPDS SSPENKSLEV SDTRFHSFSF YELKNVTNNF
     DERPISVGGN KMGEGGFGVV YKGYVNNTTV AVKKLAAMVD ITTEELKQQF DQEIKVMAKC
     QHENLVELLG FSSDGDDLCL VYVYMPNGSL LDRLSCLDGT PPLSWHMRCK IAQGAANGIN
     FLHENHHIHR DIKSANILLD EAFTAKISDF GLARASEKFA QTVMTSRIVG TTAYMAPEAL
     RGEITPKSDI YSFGVVLLEI ITGLPAVDEH REPQLLLDIK EEIEDEEKTI EDYIDKKMND
     ADSTSVEAMY SVASQCLHEK KNKRPDIKKV QQLLQEMTAS
//
